Development and Clinical Validation of Multiple Cross Displacement Amplification Combined With Nanoparticles-Based Biosensor for Detection of Mycobacterium tuberculosis: Preliminary Results

Development and Clinical Validation of Multiple Cross Displacement Amplification Combined With Nanoparticles-Based Biosensor for Detection of Mycobacterium tuberculosis: Preliminary Results

Tuberculosis is still a major threat to global public health. Here, a novel diagnosis assay, termed as multiple cross displacement amplification combined with nanoparticle-based lateral flow biosensor (MCDA-LFB), was developed to simultaneously detect IS6110 and IS1081 of Mycobacterium tuberculosis...

Full description

Bibliographic Details
Main Authors: Wei-Wei Jiao, Yi Wang, Gui-Rong Wang, Ya-Cui Wang, Jing Xiao, Lin Sun, Jie-Qiong Li, Shu-An Wen, Ting-Ting Zhang, Qi Ma, Hai-Rong Huang, A-Dong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Microbiology
Subjects:
Mycobacterium tuberculosis
multiple cross displacement amplification
lateral flow biosensor
MCDA-LFB
limit of detection
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.02135/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.02135/full

Similar Items